02 September 2025 : Original article
New-Onset Diabetes After Liver Transplantation: An SRTR Database Study of Incidence and Risk Factors
Saxiao Tang AEF 1,2, Shengmin Mei BCD 1, Shichao ShenDOI: 10.12659/AOT.949062
Ann Transplant 2025; 30:e949062
Table 5 Cause of graft failure and patient death comparison between NODAT and non-NODAT.
| Graft failure (%) | NODAT (n=459) | Non-NODAT (n=4913) | P | Patient death (%) | NODAT (n=407) | Non-NODAT (n=3559) | P |
|---|---|---|---|---|---|---|---|
| Primary non-function | 24 (5.2) | 405 (8.2) | 0.024 | Primary graft failure | 23 (5.7) | 282 (7.9) | 0.116 |
| Recurrent primary disease | 32 (7.0) | 326 (6.6) | 0.769 | Cardiovascular/cerebrovascular disease | 47 (11.5) | 412 (11.6) | 1.000 |
| Rejection | 21 (4.6) | 227 (4.6) | 1.000 | Organ failure | 64 (15.7) | 493 (13.9) | 0.293 |
| Infection | 58 (12.6) | 539 (11.0) | 0.277 | Infection | 47 (11.5) | 358 (10.1) | 0.342 |
| Vascular thrombosis | 48 (10.5) | 377 (7.7) | 0.038 | Malignancy | 76 (18.7) | 793 (22.3) | 0.100 |
| Cholangiopathy | 24 (5.2) | 259 (5.3) | 1.000 | Others | 150 (36.9) | 1221 (34.3) | 0.322 |
| Death with graft still functioning | 200 (43.6) | 1803 (36.7) | 0.004 | ||||
| Others | 52 (11.3) | 977 (19.9) | <0.001 | ||||
| NODAT – new-onset diabetes after transplantation. | |||||||






